Senphonix
Senphonix
  • Home
  • Challenge
  • Solution
  • Team
  • Partners
  • Contact
  • More
    • Home
    • Challenge
    • Solution
    • Team
    • Partners
    • Contact
  • Home
  • Challenge
  • Solution
  • Team
  • Partners
  • Contact

FINAL Market Research Report of Findings_MarketWise_Senphonix_May 2025 (pdf)

Download

SleeveSense™ will be available upon FDA clearance, which is expected in 2027.


Senphonix is a Delaware C-Corp., with offices in Minnesota and Arizona. For more information, contact us at info@senphonix.com or 612-913-0607; or follow us on LinkedIn. Copyright © 2026 Senphonix, Inc. - All Rights Reserved. Logos and trademarks are the property of their respective owners. All quotes herein are drawn from anonymous responses to two MarketWise Advising ("MarketWise") national studies, commissioned by Senphonix; some quotes were lightly edited for brevity. 

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept